ROYAL BANK OF CANADA - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 26 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$6,000
-33.3%
3,099
-1.6%
0.00%
Q2 2023$9,000
-88.9%
3,149
-89.3%
0.00%
Q1 2023$81,00029,319
+58538.0%
0.00%
Q4 2022$0
-100.0%
50
-83.3%
0.00%
Q3 2022$1,0000.0%3000.0%0.00%
Q2 2022$1,000
-50.0%
3000.0%0.00%
Q1 2022$2,000
-86.7%
300
-89.2%
0.00%
Q4 2021$15,000
-31.8%
2,767
-23.4%
0.00%
Q3 2021$22,000
+10.0%
3,611
+9.0%
0.00%
Q2 2021$20,000
+566.7%
3,312
+1004.0%
0.00%
Q1 2021$3,000
-50.0%
300
-23.3%
0.00%
Q4 2020$6,0003910.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,028,253$1,8820.09%
Gradient Capital Advisors, LLC 26,808$49,0590.02%
WEST PACES ADVISORS INC. 1,665$3,0470.00%
DIMENSIONAL FUND ADVISORS LP 15,927$29,1470.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,382$4,3590.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$31,9950.00%
CITIGROUP INC 7$130.00%
MORGAN STANLEY 533$9750.00%
Rathbones Group PLC 14,000$25,6200.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders